GSK plcNYSE:GSK
- LAST PRICE40.9850
- TODAY'S CHANGE (%)-3.7850 (-8.4543%)
- Bid / Lots40.9800/ 5
- Ask / Lots40.9900/ 5
- Open / Previous Close41.2200 / 44.7700
- Day Range
- 52 Week Range
- Volume6,683,470
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GSK |
|---|---|---|
| 09:32 ET | 36550 | 41.28 |
| 09:34 ET | 336317 | 41.225 |
| 09:36 ET | 301693 | 41.42 |
| 09:38 ET | 219248 | 41.53 |
| 09:39 ET | 202668 | 41.595 |
| 09:41 ET | 122128 | 41.66 |
| 09:43 ET | 67540 | 41.69 |
| 09:45 ET | 141535 | 41.58 |
| 09:48 ET | 192084 | 41.415 |
| 09:50 ET | 48310 | 41.41 |
| 09:52 ET | 102619 | 41.52 |
| 09:54 ET | 85663 | 41.53 |
| 09:56 ET | 31740 | 41.505 |
| 09:57 ET | 56643 | 41.395 |
| 09:59 ET | 66619 | 41.37 |
| 10:01 ET | 195584 | 41.385 |
| 10:03 ET | 41546 | 41.44 |
| 10:06 ET | 72757 | 41.3793 |
| 10:08 ET | 65674 | 41.375 |
| 10:10 ET | 97154 | 41.24 |
| 10:12 ET | 31323 | 41.27 |
| 10:14 ET | 34336 | 41.25 |
| 10:15 ET | 48200 | 41.205 |
| 10:17 ET | 82016 | 41.205 |
| 10:19 ET | 45323 | 41.16 |
| 10:21 ET | 23066 | 41.14 |
| 10:24 ET | 41776 | 41.159 |
| 10:26 ET | 9005 | 41.1 |
| 11:40 ET | 23230 | 40.635 |
| 11:42 ET | 48246 | 40.6307 |
| 11:44 ET | 26047 | 40.66 |
| 11:45 ET | 29994 | 40.65 |
| 11:47 ET | 32447 | 40.5999 |
| 11:49 ET | 24734 | 40.64 |
| 11:51 ET | 16249 | 40.595 |
| 11:54 ET | 62159 | 40.565 |
| 11:56 ET | 33577 | 40.565 |
| 11:58 ET | 33028 | 40.645 |
| 12:00 ET | 15190 | 40.64 |
| 12:02 ET | 12034 | 40.625 |
| 12:03 ET | 20498 | 40.575 |
| 12:05 ET | 24317 | 40.6291 |
| 12:07 ET | 45429 | 40.56 |
| 12:09 ET | 31114 | 40.56 |
| 12:12 ET | 31307 | 40.58 |
| 12:14 ET | 34265 | 40.56 |
| 12:16 ET | 16002 | 40.5795 |
| 12:18 ET | 22986 | 40.595 |
| 12:20 ET | 18172 | 40.605 |
| 12:21 ET | 11606 | 40.615 |
| 12:23 ET | 64370 | 40.76 |
| 12:25 ET | 26867 | 40.765 |
| 12:27 ET | 11442 | 40.755 |
| 12:30 ET | 27050 | 40.67 |
| 12:32 ET | 22717 | 40.62 |
| 12:34 ET | 43308 | 40.6 |
| 12:36 ET | 11849 | 40.55 |
| 12:38 ET | 35882 | 40.555 |
| 12:39 ET | 65452 | 40.585 |
| 12:41 ET | 45795 | 40.61 |
| 12:43 ET | 92780 | 40.6 |
| 12:45 ET | 27244 | 40.5801 |
| 12:48 ET | 34913 | 40.58 |
| 12:50 ET | 67328 | 40.56 |
| 12:52 ET | 65909 | 40.53 |
| 12:54 ET | 116920 | 40.5795 |
| 12:56 ET | 36409 | 40.67 |
| 12:57 ET | 26037 | 40.725 |
| 12:59 ET | 14336 | 40.7402 |
| 01:01 ET | 25056 | 40.785 |
| 01:03 ET | 19359 | 40.84 |
| 01:06 ET | 14319 | 40.86 |
| 01:08 ET | 17740 | 40.85 |
| 01:10 ET | 14048 | 40.7803 |
| 01:12 ET | 24021 | 40.775 |
| 01:14 ET | 14411 | 40.795 |
| 01:15 ET | 16479 | 40.815 |
| 01:17 ET | 57348 | 40.9 |
| 01:19 ET | 149099 | 40.875 |
| 01:21 ET | 14579 | 40.865 |
| 01:24 ET | 28100 | 40.83 |
| 01:26 ET | 20011 | 40.825 |
| 01:28 ET | 11485 | 40.85 |
| 01:30 ET | 9394 | 40.8625 |
| 01:32 ET | 9322 | 40.855 |
| 01:33 ET | 8144 | 40.855 |
| 01:35 ET | 14919 | 40.87 |
| 01:37 ET | 8778 | 40.875 |
| 01:39 ET | 8477 | 40.895 |
| 01:42 ET | 19719 | 40.925 |
| 01:44 ET | 28851 | 40.935 |
| 01:46 ET | 34328 | 40.98 |
| 01:48 ET | 5415 | 40.9892 |
Today
DJ Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesDJ GSK Down Nearly 9%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesDJ Trending: GSK Shares Tumble on Zantac's Legal Setback, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDJ GSK's Zantac Ruling Is a Surprise, But Should Have Limited Effect -- Market Talk, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesJemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
GSK plc | 93.2B | 14.7x | +6.39% |
Sanofi SA | 123.1B | 25.1x | +4.55% |
Bristol-Myers Squibb Co | 83.3B | -13.5x | +4.90% |
Pfizer Inc | 162.4B | -480.9x | -7.10% |
Novartis AG | 226.2B | 23.4x | -5.59% |
Bayer AG | 30.1B | -9.1x | --- |
Company Information
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Contact Information
- Headquarters
- 980 Great West RoadBRENTFORD, United Kingdom TW8 9GS
- Phone
- 208-047-5000
- Fax
- 208-047-7807
Executives
- Independent Non-Executive Chairman of the Board
- Jonathan Symonds
- Chief Executive Officer, Executive Director
- Emma Walmsley
- Chief Financial Officer, Executive Director
- Julie Brown
- President - Corporate Development
- David Redfern
- President - Global Supply Chain
- Regis Simard
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $93.2B |
|---|---|
Revenue (TTM) | $39.2B |
Shares Outstanding | 2.1B |
Dividend Yield | 3.61% |
Annual Dividend Rate | 1.4810 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 07-11-24 |
Beta | 0.67 |
EPS | $2.78 |
Book Value | $8.38 |
P/E Ratio | 14.7x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 10.5x |
Operating Margin | 20.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
